Physician profile
Lance Frye
NPI 1649321415
$5,463.07
in general payments reported to CMS, 2019-2025
15 companies · $99.07 in 2025
The $99.07 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,848 · 2020: $1,841 · 2021: $18.77 · 2022: $438 · 2023: $138 · 2024: $79.08 · 2025: $99.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $3,835.00 | 2019-2020 | |
| Abbvie INC. | $351.37 | 2019-2021 | |
| Intuitive Surgical, INC. | $138.77 | 2022 | |
| Axonics, INC. | $135.82 | 2022 | |
| Silk Road Medical, INC. | $129.91 | 2022 | |
| Baxter Healthcare | $124.08 | 2024-2025 | Perclot, Seprafilm |
| Si-Bone, INC. | $123.91 | 2019 | |
| Covidien LP | $120.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.45 | 2023 | Ofev |
| Davol INC. | $106.40 | 2020 | |
| Amag Pharmaceuticals, INC. | $102.45 | 2019 | |
| Hologic Sales and Service, LLC | $90.38 | 2022-2025 | Thinprep 2000 Processor, Aptima, Omni Hysteroscope |
| Convatec INC. | $47.70 | 2019 | |
| Allergan, INC. | $20.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Frye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.